Cat.#: ACPP-1222
| Despition | ALDH1A1 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1649 | Human EFNA5 Protein (AC1649) | 2 µg | inquiry |
| ACPP-1266 | ROR1 Blocking Peptide (AC1266) | 250 µg | inquiry |
| ACPP-1644 | Human Vimentin Protein (AC1644) | 20 µg | inquiry |
| ACPP-1585 | Human SERPINI1 Protein, His (AC1585) | 2 µg | inquiry |
| ACPP-1522 | Dopamine Receptor D3 Blocking Peptide (AC1522) | 250 µg | inquiry |
| ACPP-1212 | PAX8 Blocking Peptide (AC1212) | 250 µg | inquiry |
| ACPP-1096 | Synthetic Nanodisc Human CXCR4 Protein (AC1096) | 10 µg | inquiry |
| ACPP-1217 | P2Y2 Blocking Peptide (AC1217) | 250 µg | inquiry |
| ACPP-1157 | Recombinant Human GFAP Protein (6×His Tag) (AC1157) | 50 µg | inquiry |
| ACPP-1795 | Human STXBP6 Protein (AC1795) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.